Geneos Wealth Management’s iShares MSCI EAFE Min Vol Factor ETF EFAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.4M Sell
209,918
-4,004
-2% -$363K 0.38% 59
2026
Q1
$19.5M Buy
213,922
+106,290
+99% +$9.6M 0.45% 49
2025
Q4
$9.28M Buy
107,632
+2,798
+3% +$239K 0.23% 111
2025
Q3
$8.89M Sell
104,834
-5,187
-5% -$438K 0.23% 113
2025
Q2
$9.25M Sell
110,021
-136,135
-55% -$11.1M 0.23% 107
2025
Q1
$19.2M Buy
246,156
+135,710
+123% +$10.1M 0.28% 86
2024
Q4
$7.81M Buy
110,446
+219
+0.2% +$16.1K 0.27% 81
2024
Q3
$8.45M Buy
110,227
+1,679
+2% +$124K 0.32% 69
2024
Q2
$7.53M Buy
108,548
+5,424
+5% +$381K 0.33% 70
2024
Q1
$7.31M Sell
103,124
-38,135
-27% -$2.65M 0.33% 67
2023
Q4
$9.79M Sell
141,259
-1,499
-1% -$99.4K 0.48% 46
2023
Q3
$9.31M Sell
142,758
-7,076
-5% -$475K 0.48% 40
2023
Q2
$10.1M Buy
149,834
+386
+0.3% +$26.6K 0.53% 38
2023
Q1
$10.1M Sell
149,448
-1,553
-1% -$102K 0.61% 26
2022
Q4
$9.6M Sell
151,001
-20,311
-12% -$1.24M 0.58% 31
2022
Q3
$9.77M Sell
171,312
-158,633
-48% -$9.95M 0.67% 25
2022
Q2
$21M Sell
329,945
-15,586
-5% -$1.05M 1.04% 16
2022
Q1
$24.9M Buy
345,531
+4,925
+1% +$357K 1.07% 14
2021
Q4
$26.1M Buy
340,606
+16,954
+5% +$1.29M 1% 14
2021
Q3
$24.4M Buy
323,652
+12,824
+4% +$996K 0.93% 16
2021
Q2
$23.6M Buy
310,828
+119,146
+62% +$8.98M 0.92% 18
2021
Q1
$14.2M Sell
191,682
-4,641
-2% -$341K 0.4% 60
2020
Q4
$14.1M Buy
196,323
+20,708
+12% +$1.46M 0.57% 35
2020
Q3
$11.9M Buy
175,615
+5,272
+3% +$359K 0.62% 30
2020
Q2
$11.2M Buy
170,343
+15,985
+10% +$1.04M 0.63% 29
2020
Q1
$9.49M Sell
154,358
-445
-0.3% -$31.3K 0.64% 25
2019
Q4
$11.6M Buy
154,803
+7,501
+5% +$559K 0.62% 24
2019
Q3
$10.8M Buy
147,302
+32,877
+29% +$2.38M 0.65% 23
2019
Q2
$8.31M Sell
114,425
-61,182
-35% -$4.4M 0.52% 41
2019
Q1
$12.6M Sell
175,607
-7,707
-4% -$540K 0.83% 14
2018
Q4
$12.2M Buy
183,314
+60,900
+50% +$4.18M 0.9% 13
2018
Q3
$8.91M Buy
122,414
+6,531
+6% +$471K 0.59% 28
2018
Q2
$8.24M Sell
115,883
-42,223
-27% -$3.1M 0.64% 27
2018
Q1
$11.7M Buy
158,106
+53,070
+51% +$3.92M 1.02% 12
2017
Q4
$7.67M Buy
105,036
+13,357
+15% +$962K 0.68% 28
2017
Q3
$6.51M Sell
91,679
-2,487
-3% -$175K 0.65% 31
2017
Q2
$6.52M Buy
94,166
+12,267
+15% +$846K 0.67% 33
2017
Q1
$5.41M Buy
81,899
+48,557
+146% +$3.11M 0.56% 40
2016
Q4
$2.04M Sell
33,342
-37,985
-53% -$2.4M 0.27% 95
2016
Q3
$4.82M Buy
71,327
+13,803
+24% +$929K 0.65% 34
2016
Q2
$3.86M Sell
57,524
-437
-0.8% -$29.2K 0.56% 38
2016
Q1
$3.81M Buy
+57,961
New +$3.69M 0.58% 35

Other funds holding EFAV

Geneos Wealth Management's EFAV Position: Q2 2026 in Review

Geneos Wealth Management reduced its iShares MSCI EAFE Min Vol Factor ETF (EFAV) stake by 1.9% in Q2 2026, selling an estimated $363K and leaving 209,918 shares worth $18.4M. The position accounts for 0.38% of the portfolio, ranked #59.

Geneos Wealth Management first reported a position in EFAV in Q1 2016 and has held it in 42 quarters since. The position peaked at $26.1M in Q4 2021. 529 funds tracked by Wall St. Rank hold EFAV as of Q2 2026.

  • Geneos Wealth Management held 209,918 shares of iShares MSCI EAFE Min Vol Factor ETF worth $18.4M as of Q2 2026.
  • Geneos Wealth Management sold 4,004 iShares MSCI EAFE Min Vol Factor ETF shares in Q2 2026, an estimated $363K.
  • iShares MSCI EAFE Min Vol Factor ETF made up 0.38% of Geneos Wealth Management's portfolio in Q2 2026, its #59 holding.
  • Geneos Wealth Management first reported a position in iShares MSCI EAFE Min Vol Factor ETF in Q1 2016 and has held it in 42 quarters since.
  • Geneos Wealth Management's iShares MSCI EAFE Min Vol Factor ETF position peaked at $26.1M in Q4 2021.
  • 529 funds tracked by Wall St. Rank held iShares MSCI EAFE Min Vol Factor ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.